Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin 300 mg/day for postherpetic neuralgia in Chinese adults
CTR20132986Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Apr 2015; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20132986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132986.